Advertisement
Journal Home
Search for

Issue

Alert me when new journal issues are available via Request TOC Alert via emailor via Request RSS feed of current issue

previous issue next issue

Seminars in Hematology
Volume 43, Supplement 1 (January 2006)
Search Within This Issue
8th Novo Nordisk Symposium on Haemostasis Management and Novo Nordisk-Sponsored Symposia at the XXth Congress of the International Society on Thrombosis and Haemostasis
2005 - 2005
Edited by Gilbert C. White
Novo Nordisk

display abstract citation download email a colleague
Display:

free full text =free full text


Masthead free full text
page CO2
Full-Text PDF (34 KB)


Introduction
Gilbert C. White
pages S1-S2
Full Text | Full-Text PDF (51 KB)

8th Novo Nordisk Symposium on Haemostasis Management

Paper


Impact of Choice of Treatment for Bleeding Episodes on Inhibitor Outcome in Patients With Mild/Moderate Hemophilia A and Inhibitors
Roseline d’Oiron, F. Volot, J. Reynaud, K. Peerlinck, J. Goudemand, C. Guérois, C. Rothschild, H. Chambost, A. Borel-Derlon, V. Roussel-Robert, A. Marquès-Verdier, A. Lienhart, A.M. Berthier, P. Moreau, T. Lambert, MHAI Study Group
pages S3-S9
Abstract | Full Text | Full-Text PDF (117 KB)


Inhibitors to Factor XI in Patients With Severe Factor XI Deficiency
Ophira Salomon, Ariella Zivelin, Tami Livnat, Uri Seligsohn
pages S10-S12
Abstract | Full Text | Full-Text PDF (84 KB)


Update on Liver Disease in Hemophilia Patients
Craig M. Kessler
pages S13-S17
Abstract | Full Text | Full-Text PDF (98 KB)


Pathogenesis of Hemophilic Arthropathy
W. Keith Hoots
pages S18-S22
Abstract | Full Text | Full-Text PDF (281 KB)


Surgery in Hemophilia. The General View: Patient Selection, Timing, and Preoperative Assessment
Jørgen Ingerslev, Ivan Hvid
pages S23-S26
Abstract | Full Text | Full-Text PDF (74 KB)


Functional Assessment of Arthropathy—An International Perspective
Pradeep M. Poonnoose, Alok Srivastava
pages S27-S32
Abstract | Full Text | Full-Text PDF (126 KB)


Glanzmann’s Thrombasthenia Treatment: A Prospective Observational Registry on the Use of Recombinant Human Activated Factor VII and Other Hemostatic Agents
Man-Chiu Poon, Rainer Zotz, Giovanni Di Minno, Zvika S. Abrams, Jens B. Knudsen, Yves Laurian
pages S33-S36
Abstract | Full Text | Full-Text PDF (82 KB)


Congenital and Acquired Platelet Disorders: Current Dilemmas and Treatment Strategies
Gilbert C. White
pages S37-S41
Abstract | Full Text | Full-Text PDF (90 KB)


Steps Towards an Effective Treatment Strategy in Congenital Factor VII Deficiency
Guglielmo Mariani, Mario Lapecorella, Alberto Dolce
pages S42-S47
Abstract | Full Text | Full-Text PDF (196 KB)


Acquired von Willebrand Syndrome: An Underdiagnosed and Misdiagnosed Bleeding Complication in Patients With Lymphoproliferative and Myeloproliferative Disorders
Augusto B. Federici
pages S48-S58
Abstract | Full Text | Full-Text PDF (559 KB)


Massive Transfusion Coagulopathy
Jerrold H. Levy
pages S59-S63
Abstract | Full Text | Full-Text PDF (182 KB)


Assessing Efficacy and Therapeutic Claims in Emerging Indications for Recombinant Factor VIIa: Regulatory Perspectives
Albert Farrugia
pages S64-S69
Abstract | Full Text | Full-Text PDF (110 KB)


Ultra-early Hemostatic Therapy for Acute Intracerebral Hemorrhage
Stephan A. Mayer, Fred Rincon
pages S70-S76
Abstract | Full Text | Full-Text PDF (219 KB)


New Anti-thrombotic Agents: Emphasis on Hemorrhagic Complications and Their Management
Heng Joo Ng, Mark A. Crowther
pages S77-S83
Abstract | Full Text | Full-Text PDF (153 KB)


Milestones in Hemophilia and Concepts in Future Clinical Trial Design
Jeanne M. Lusher
pages S84-S87
Abstract | Full Text | Full-Text PDF (78 KB)

Abstract


The Incidence of Factor VIII and Factor IX Inhibitors in the Hemophilia Population of the UK and Their Effect on Subsequent Mortality, 1977–991*
Sarah C. Darby, David M. Keeling, Rosemary J.D. Spooner, Sau Wan Kan, Paul L.F. Giangrande, Peter W. Collins, Frank G.H. Hill, Charles R.M. Hay
page S88
Full Text | Full-Text PDF (47 KB)


Intensive Exposure to Factor VIII May Be a Risk Factor for Inhibitor Development in Mild Hemophilia A
Carcao Manuel D.
page S89
Full Text | Full-Text PDF (45 KB)


Acquired Hemophilia
Peter Collins
page S90
Full Text | Full-Text PDF (48 KB)


Recombinant Activated Factor VII in Severe Trauma
Bruno Riou
pages S91-S92
Full Text | Full-Text PDF (57 KB)

XXth Congress of the International Society on Thrombosis and Haemostasis

Paper


The Platelet: Form and Function
John H. Hartwig
pages S94-S100
Abstract | Full Text | Full-Text PDF (1158 KB)


Advances in Gene Therapy Using Factor VIIa in Hemophilia
Paris Margaritis, Katherine A. High
pages S101-S104
Abstract | Full Text | Full-Text PDF (190 KB)


Mechanism of Action of Recombinant Activated Factor VII: An Update
Ulla Hedner
pages S105-S107
Abstract | Full Text | Full-Text PDF (69 KB)


High-Dose Recombinant Factor VIIa Therapy in Hemophilia Patients With Inhibitors
Gili Kenet
pages S108-S110
Abstract | Full Text | Full-Text PDF (80 KB)

Haemostasis Award Winner


Protein S Multimers Are Generated In Vitro and Affect Protein S Structure-Function Analyses
Kristin M. Seré, George M. Willems, Jan Rosing, Tilman M. Hackeng
pages S111-S120
Abstract | Full Text | Full-Text PDF (261 KB)

Abstract


Dynamics of Thrombus Formation
Bruce Furie
page S121
Full Text | Full-Text PDF (133 KB)


Recombinant Factor VIIa and COAT Platelets
Marianne Kjalke, Rasmus Rojkjaer
page S122
Full Text | Full-Text PDF (38 KB)

Frontmatter


Table of Contents free full text
pages A1-A3
Full-Text PDF (40 KB)


Supplement Disclaimer free full text
page A4
Full-Text PDF (21 KB)

display abstract citation download email a colleague
Display:
Advertisement